We Can Medicines Co., Ltd.(TW:6929)
NT$21.15+0.30 (+1.44%)
TW:6929
We Can Medicines Co., Ltd. Revenue
NT$21.15
At close:+0.30 (+1.44%)
We Can Medicines Co., Ltd. (6929) Revenue
We Can Medicines Co., Ltd. Revenue
We Can Medicines Co., Ltd. had a revenue of 802.61M in the quarter ending Jun 30, 2026, with 0.72%. This bring the company's revenue in the last twelve months to 3.21B, Decreased 0.44%. In the fiscal year ending Dec 31, 2025, We Can Medicines Co., Ltd. had annual revenue of 3.22B with -1.45% growth.
- Revenue (ttm)
- 3.21B
- Revenue Growth
- -1.09%
- P/S Ratio
- 0.30
- Revenue/Employee
- TWD 3,158,630
- Employees
- 1,020
- Market Cap
- TWD 953.65M
Revenue Chart
We Can Medicines Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.22B | -47.40M | -1.45% |
| Dec 31, 2024 | 3.27B | 146.31M | 4.69% |
| Dec 31, 2023 | 3.12B | -179.84M | -5.45% |
| Dec 31, 2022 | 3.30B | 508.66M | 18.21% |
| Dec 31, 2021 | 2.79B | 127.32M | 4.77% |
| Dec 31, 2020 | 2.67B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.